Understanding disease
We create deep learning representations of cancer that uncover more profound insights than ever before.
Reinventing diagnostic medicine
Our largely unsupervised approaches will rebuild pathology from first principles using a data-driven approach and unlock previously inaccessible insights.
Eliminating Human Error
Automate tedious and error-prone tasks like cell counts and morphological analysis and do more of what humans excel at.
Augmented Diagnosis
Receive insights on previously inaccessible features of patient biopsies, including information on the bone marrow niche.
Unprecedented Functionality
Advanced prognostics, therapy recommendation, relapse detection, biomarker discovery, and more.
Online demo coming soon.
Stay updated:
Team
Andrew Leber
Andrew has experience in leukemia research and biomedical deep learning software development, as well as experience founding StrainBrain and the McMaster AI Society.
Dr. Clinton Campbell, MD, PhD, FRCPC
Clinton has over a decade of experience as a practicing hematopathologist, as well as a strong research background in blood cancers and world-class expertise in digital pathology.
Supported by
